Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Durrant

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|June 19, 1991
Intracellular gastrin in human gastrointestinal tumor cellsS A Watson, L G Durrant, P M Wencyk, et al.
Immunology|August 1, 1989
Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36E B Austin, R A Robins, L G Durrant, et al.
The International Journal of Biological Markers|July 17, 2004
MUC3 and MCA serum levels and steroid receptor content in breast cancerM Quaranta, M Coviello, A Daniele, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Production of a human monoclonal antibody recognising a determinant on mouse IgG2b from a patient receiving mouse monoclonal antibody for diagnostic imagingL G Durrant, R A Robins, K C Ballantyne, et al.
Cancer Research|June 24, 2000
Vaccine-induced apoptosis: a novel clinical trial end point?S Amin, R A Robins, C A Maxwell-Armstrong, et al.
Vaccine|August 17, 2004
A novel CEA vaccine stimulates T cell proliferation, gammaIFN secretion and CEA specific CTL responsesT Parsons, I Spendlove, R Nirula, et al.
Mabs|January 5, 2010
Antibodies designed as effective cancer vaccinesR L Metheringham, V A Pudney, B Gunn, et al.
Clinical Chemistry|June 1, 1996
Greater frequency of K-ras Val-12 mutation in colorectal cancer as detected with sensitive methodsK M Carpenter, L G Durrant, K Morgan, et al.
Journal of Immunological Methods|February 26, 1993
Measurement of antibody binding to antigenic peptides conjugated in situ to albumin-coated microtitre platesM R Price, M Sekowski, D S Hooi, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2003
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patientsL G Durrant, M A Chapman, D J Buckley, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|June 19, 1991
Intracellular gastrin in human gastrointestinal tumor cellsS A Watson, L G Durrant, P M Wencyk, et al.
Immunology|August 1, 1989
Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36E B Austin, R A Robins, L G Durrant, et al.
The International Journal of Biological Markers|July 17, 2004
MUC3 and MCA serum levels and steroid receptor content in breast cancerM Quaranta, M Coviello, A Daniele, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Production of a human monoclonal antibody recognising a determinant on mouse IgG2b from a patient receiving mouse monoclonal antibody for diagnostic imagingL G Durrant, R A Robins, K C Ballantyne, et al.
Cancer Research|June 24, 2000
Vaccine-induced apoptosis: a novel clinical trial end point?S Amin, R A Robins, C A Maxwell-Armstrong, et al.
Vaccine|August 17, 2004
A novel CEA vaccine stimulates T cell proliferation, gammaIFN secretion and CEA specific CTL responsesT Parsons, I Spendlove, R Nirula, et al.
Mabs|January 5, 2010
Antibodies designed as effective cancer vaccinesR L Metheringham, V A Pudney, B Gunn, et al.
Clinical Chemistry|June 1, 1996
Greater frequency of K-ras Val-12 mutation in colorectal cancer as detected with sensitive methodsK M Carpenter, L G Durrant, K Morgan, et al.
Journal of Immunological Methods|February 26, 1993
Measurement of antibody binding to antigenic peptides conjugated in situ to albumin-coated microtitre platesM R Price, M Sekowski, D S Hooi, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2003
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patientsL G Durrant, M A Chapman, D J Buckley, et al.
Pageof 9